ResMetrix Medical

Company Overview

Snapshot

Founded in July 2017 by Ari DeRowe and Zvi Reznic, ResMetrix Medical operates with 1–10 employees. The company has raised $750,000 across one funding round from two investors. In January 2018, ResMetrix Medical secured seed funding from the Israel Innovation Authority and MindUP.

Business overview

ResMetrix Medical develops a wearable technology designed for continuous respiratory monitoring of patients with conditions like asthma and COPD. Its core product is a sensor integrated into a chest strap or patch that wirelessly connects to a smartphone app, displaying real-time respiratory parameters and vital signs. The system utilizes an AI-powered algorithm to assess disease progression and provide early warnings of exacerbations, aiming to prevent hospitalizations. The company serves the digital healthcare market, focusing on patient remote monitoring within the Health Tech & Life Sciences sector.

Strategic signal

In April 2020, ResMetrix Medical adapted its remote monitoring technology to detect respiratory worsening in COVID-19 patients. This development demonstrates the company's ability to rapidly pivot its technology for emerging health crises, highlighting the versatility and critical relevance of its wearable respiratory monitoring system in broader public health contexts.

Company Intelligence Q&A

When was ResMetrix Medical founded?

ResMetrix Medical was founded in July 2017.

Who are the founders of ResMetrix Medical?

ResMetrix Medical was co-founded by Ari DeRowe and Zvi Reznic.

What was a significant development for ResMetrix Medical in 2020?

In April 2020, ResMetrix Medical developed a remote application to detect respiratory worsening in COVID-19 patients, showcasing the adaptability of its technology.

What type of funding did ResMetrix Medical receive in January 2018?

In January 2018, ResMetrix Medical secured seed funding from the Israel Innovation Authority and MindUP.